Показано 0 из 0
Дата |
---|
03.05.2024 |
02.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
19.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
|
|
670.00
|
658.50
|
674.55
|
671.20
|
|
|
1 170 870.00
|
268.00
|
|
|
667.70
|
659.00
|
672.00
|
669.50
|
|
|
2 641 554.00
|
424.00
|
|
|
652.55
|
645.05
|
664.30
|
658.05
|
|
|
1 713 126.00
|
189.00
|
|
|
660.00
|
640.35
|
660.00
|
644.45
|
|
|
4 826 661.00
|
485.00
|
|
|
652.45
|
649.75
|
664.10
|
657.90
|
|
|
2 594 146.00
|
390.00
|
|
|
635.20
|
635.20
|
649.00
|
644.85
|
|
|
3 804 959.00
|
290.00
|
|
|
644.75
|
635.20
|
647.35
|
636.75
|
|
|
1 063 932.00
|
165.00
|
|
|
628.45
|
626.90
|
648.80
|
643.85
|
|
|
3 742 627.00
|
591.00
|
|
|
644.00
|
633.10
|
649.55
|
637.60
|
|
|
4 136 212.00
|
507.00
|
|
|
640.75
|
632.75
|
648.85
|
642.30
|
|
|
3 468 250.00
|
421.00
|
Период |
---|
2021, регулярные |
2021, Внеплановые |
2021, регулярные |
2021, Внеплановые |
2021, регулярные |
2020, регулярные |
2020, регулярные |
2018, регулярные |
2017, регулярные |
2016, регулярные |
Экс-дивидендная дата
|
Закрытие реестра |
Сумма выплаты |
---|---|---|
08.09.2022
|
12.09.2022 |
1 INR |
08.09.2022
|
12.09.2022 |
5 INR |
12.05.2022
|
17.05.2022 |
1 INR |
14.02.2022
|
16.02.2022 |
2 INR |
14.02.2022
|
16.02.2022 |
1 INR |
12.08.2021
|
17.08.2021 |
1 INR |
16.02.2021
|
18.02.2021 |
1 INR |
13.02.2019
|
15.02.2019 |
1.5 INR |
05.02.2018
|
07.02.2018 |
1.5 INR |
07.02.2017
|
09.02.2017 |
1 INR |
Suven Pharmaceuticals Limited (SPL) is a bio-pharmaceutical company incorporated on 6th November 2018 and is engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates Active Pharmaceutical Ingredients (API) Speciality Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical biotechnology and chemical companies.